Loading…
LB Pharmaceuticals Inc is projected to rise to $38.76 by 2027, a +39% move from its current price of $27.80. LBRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $27.05 | $27.81 | $28.59 | +0.04% |
| May 30 | $26.75 | $27.82 | $28.93 | +0.07% |
| May 31 | $26.52 | $27.83 | $29.20 | +0.11% |
| Jun 1 | $26.34 | $27.84 | $29.43 | +0.14% |
| Jun 2 | $26.17 | $27.85 | $29.63 | +0.18% |
| Jun 3 | $26.03 | $27.86 | $29.82 | +0.21% |
| Jun 4 | $25.90 | $27.87 | $29.99 | +0.25% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $25.90 | $27.87 | $29.99 | +0.25% |
| Week 2 | $25.18 | $27.94 | $31.00 | +0.50% |
| Week 3 | $24.66 | $28.01 | $31.81 | +0.75% |
| Week 4 | $24.24 | $28.08 | $32.52 | +1.00% |
| Week 5 | $23.88 | $28.15 | $33.17 | +1.25% |
| Week 6 | $23.57 | $28.22 | $33.78 | +1.50% |
| Week 7 | $23.29 | $28.29 | $34.36 | +1.75% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company in the Healthcare sector that develops therapies for schizophrenia, bipolar depression, and other neuropsychiatric diseases.
Its lead product is LB-102, a small molecule oral therapy in Phase 3 for acute schizophrenia. It has completed Phase 2 for bipolar I depression and adjunctive treatment of major depressive disorder, and is in pre-clinical development for an LAI formulation.
The company was incorporated in 2015 and is headquartered in New York, New York.
LB Pharmaceuticals Inc (LBRX) is trading at $28.12, with a market cap of $806.39M. It is ranked 2689.
The near-term technical picture shows a neutral sentiment with RSI14 at 40 and the 50-day simple moving average at $28.11.
The 30-day range is $23.20 to $34.08, with support at $25.43 and resistance at $32.88. Annualized volatility is 60%.
A major floor 28.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.9% away) — a key level to hold.
The nearest ceiling, 18.3% above — a clean break opens room to run.
A major ceiling 25.6% above — clearing it would confirm fresh momentum.
Key LBRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LBRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $28.06 | Sell | $28.17 | Sell |
| MA 10 | $28.87 | Sell | $28.79 | Sell |
| MA 20 | $30.34 | Sell | $29.37 | Sell |
| MA 50 | $28.19 | Sell | $28.33 | Sell |
| MA 100 | $25.53 | Buy | $26.02 | Buy |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.08 | Neutral |
| Stoch RSI (14) | 11.68 | Buy |
| CCI (20) | -95.27 | Neutral |
| Williams %R (14) | -90.23 | Info |
| MACD (12,26,9) | -0.55 | Sell |
| ROC (12) | -13.04 | Sell |
| Bollinger %B (20,2) | 0.17 | Neutral |
| Stochastic %K (14) | 9.77 | Buy |
| TRIX (15) | 0.15 | Buy |
| Awesome (5,34) | -1.87 | Sell |
| Ultimate (7,14,28) | 30.79 | Neutral |
| Momentum (10) | -3.33 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 27.89 | Sell |
| ADX (14) | 19.21 | Neutral |
| ATR (14) | 0.73 | Info |
The 30-day technical picture shows Neutral sentiment with RSI14 at 40.
The 50-day simple moving average is $28.11. The 30-day price range runs from $23.20 to $34.08, with key support at $25.43 and resistance at $32.88.
Key levels to watch are support at $25.43 and resistance at $32.88.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.03 | $27.80 | $38.95 | 0% | Neutral | |
| $29.17 | $38.76 | $55.35 | +39% | Bullish | |
| $35.01 | $48.60 | $73.01 | +75% | Bullish | |
| $43.69 | $62.97 | $98.39 | +127% | Bullish | |
| $54.79 | $81.67 | $131.90 | +194% | Bullish | |
| $58.28 | $89.61 | $148.95 | +222% | Bullish | |
| $65.35 | $103.49 | $176.48 | +272% | Bullish | |
| $72.51 | $118.08 | $206.05 | +325% | Bullish | |
| $70.81 | $118.47 | $211.15 | +326% | Bullish | |
| $86.86 | $149.16 | $271.09 | +437% | Bullish | |
| $134.31 | $260.70 | $513.83 | +838% | Bullish | |
| $279.74 | $621.64 | $1,375.50 | +21.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $19.03 | $27.80 | $33.05 | +0.00% |
| June 2026 | $24.43 | $29.02 | $35.53 | +4.39% |
| July 2026 | $23.86 | $28.71 | $35.87 | -1.06% |
| August 2026 | $23.55 | $28.64 | $36.33 | -0.27% |
| September 2026 | $24.06 | $29.51 | $37.90 | +3.04% |
| October 2026 | $23.86 | $29.49 | $38.30 | -0.07% |
| November 2026 | $23.09 | $28.73 | $37.69 | -2.56% |
| December 2026 | $23.49 | $29.42 | $38.95 | +2.40% |
Click any year to see its month-by-month LBRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, LBRX could reach as high as $38.95, with a base case around $27.80 and support toward $19.03 — roughly 0% from $27.80. A consolidation phase looks the most probable path here.
Expect LBRX to range from $29.17 to $55.35 through 2027. The $38.76 average target implies a +39% move from current prices. That is up +39% on the projected 2026 average. Momentum favours further upside here.
The LBRX price prediction for 2028 points to an average of $48.60 (low $35.01, high $73.01) — a potential gain of +75% on today's $27.80. Buyers look set to stay in control over this stretch.
In 2029, LBRX is projected to trade between $43.69 and $98.39, averaging $62.97 — a potential gain of +127% from today's $27.80. That is up +30% on the projected 2028 average. Momentum favours further upside here.
LB Pharmaceuticals Inc's 2030 outlook centres on $81.67, within a $54.79 to $131.90 range. That is up +30% on the projected 2029 average. That marks a +194% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, LBRX could reach as high as $148.95, with a base case around $89.61 and support toward $58.28 — roughly +222% from $27.80. Momentum favours further upside here.
Expect LBRX to range from $65.35 to $176.48 through 2032. The $103.49 average target implies a +272% move from current prices. That is up +15% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The LBRX price prediction for 2033 points to an average of $118.08 (low $72.51, high $206.05) — a potential gain of +325% on today's $27.80. Momentum favours further upside here.
In 2034, LBRX is projected to trade between $70.81 and $211.15, averaging $118.47 — a potential gain of +326% from today's $27.80. That is up 0% on the projected 2033 average. Buyers look set to stay in control over this stretch.
LB Pharmaceuticals Inc's 2035 outlook centres on $149.16, within a $86.86 to $271.09 range. That is up +26% on the projected 2034 average. That marks a +437% change versus current levels. Momentum favours further upside here.
By 2040, LBRX could reach as high as $513.83, with a base case around $260.70 and support toward $134.31 — roughly +838% from $27.80. Buyers look set to stay in control over this stretch.
Expect LBRX to range from $279.74 to $1,375.50 through 2050. The $621.64 average target implies a +21.4x move from current prices. That is up +138% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in LBRX today (≈ 35.971223 LBRX) could be worth
$22,361.02
+$21,361.02 (+2136%) by 2050 · US Dollar
Based on the average projected LBRX price of $621.64 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LBRXwould be worth at today's price.
$1,000 invested in LBRX on Sep 11, 2025 (≈ 57.803471 LBRX) would be worth
$1,606.94
+$606.94 (+60.7%) today · 1.61× · US Dollar
Based on a LBRX entry price of $17.3 vs. today's $27.8.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $28.03 | $991.79 | -0.8% |
| 1 month ago | $31.81 | $873.94 | -12.6% |
| 3 months ago | $24.23 | $1,147.34 | +14.7% |
| 6 months ago | $17.79 | $1,562.68 | +56.3% |
| All time ago | $17.3 | $1,606.94 | +60.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LBRX forecast.
Our base-case forecast reaches $56.00 around 2029.
Implied market cap at $56.00: $1.61B
From 2026 through 2050, the forecast shows a strong upward trajectory. The 2026 average price is $28.12 with a min of $19.03 and a max of $39.88, ROI 0, and sentiment NEUTRAL. In 2027 the average is $39.33 (min $29.35, max $56.74) with ROI 39.9 and bullish sentiment; 2028 shows $49.77 (min $35.46, max $75.67) with ROI 77 and bullish mood; 2029 projects $64.88 (min $44.42, max $102.75) with ROI 130.7 and bullish outlook.
By 2030 the average is $83.33 (min $55.05, max $136.56) with ROI 196.3 and bullish sentiment. The rise continues through 2031 ($91.01 avg), 2032 ($105.38), 2033 ($119.23), 2034 ($119.20), and 2035 ($153.68), all with bullish sentiment and double- or triple-digit ROI reaching 446.5% by 2035. The forecast shows further upside in 2040 (avg $262.36; min $130.43, max $527.93; ROI 833; bullish) and in 2050 (avg $641.87; min $288.84, max $1,454.53; ROI 2182.6; bullish).
These figures are estimates and not guaranteed.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $83.33, with a min of $55.05 and a max of $136.56. The ROI is 196.3% and sentiment is BULLISH.
The long-term outlook shows bullish sentiment from 2027 onward and rising average prices through 2050, with ROIs of 39.9% (2027), 77% (2028), 130.7% (2029), 196.3% (2030), 833% (2040), and 2,182.6% (2050). These are estimates, not guarantees.
Yes. The 2029 max price is $102.75, and the 2030 max price is $136.56, so a price above $100 is forecast in the horizon.
The 2040 forecast shows an average price of $262.36, with a min of $130.43 and a max of $527.93, ROI of 833, and bullish sentiment.
The current price is $28.12 and the market cap is $806.39M.
LB Pharmaceuticals Inc Community Discussion
0Share your LB Pharmaceuticals Inc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.